Journals / Haseki Tıp Bülteni / 2019 / Cilt: 57 - Sayı: 4

Is Focused Parathyroidectomy Effective in Primary Hyperparathyroidism?

Primer Hiperparatiroidide Odaklanmış Paratiroidektomi Etkin midir?

Pages
345–348
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Localization studies are carried out meticulously in our series and therefore surgical success is increasing.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Primary hyperparathyroidism is an endocrine disease characterised by hypercalcemia due to increased parathormone (PTH) secretion.
📊
Key Findings & Data:Methods: Patients, who underwent parathyroid surgery in our clinic between 2013 and 2017, were retrospectively evaluated.
💡
Conclusion & Impact:Localization studies are carried out meticulously in our series and therefore surgical success is increasing.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Primary hyperparathyroidism is an endocrine disease characterised by hypercalcemia due to increased parathormone (PTH) secretion. Treatment is surgical excision of pathologic glands by bilateral exploration of the parathyroid glands or focused parathyroidectomy. Our aim was to evaluate the results of patients who underwent parathyroid surgery for primary hyperparathyroidism. Methods: Patients, who underwent parathyroid surgery in our clinic between 2013 and 2017, were retrospectively evaluated. Data on demographic characteristics, preoperative PTH, calcium, phosphorus, albumin, and vitamin D levels, parathyroid scintigraphy or single photon emission computed tomography, and neck ultrasonography findings, additional investigations, surgical procedure, postoperative PTH and calcium levels, results of pathological investigations, complications, and persistence and recurrence rates were recorded. Patients with missing data and secondary hyperparathyroidism were excluded. Results: The median age of 59 patients was 56±11.2 years and the female-to-male ratio was 43/16 preoperative PTH level 272±171 ng/L and calcium level was 11.8±0.68 mg/dL. The median follow-up period was 22 (3-56) months. Ten patients (16.9%) were symptomatic, 49 (83.1%) were asymptomatic. 50.8 of the patients underwent focused parathyroidectomy, 1.7%—bilateral exploration, 18.6%—unilateral exploration. Eighteen-point-six percent underwent thyroid lobectomy and 10.2% underwent bilateral total thyroidectomy due to additional thyroid pathology. Thyroid lobectomy was performed in one patient because of suspicion of parathyroid cancer. Conclusion: The most important factors affecting the surgical success of primary hyperparathyroidism are the accurate diagnosis before surgery and to accurately identify the localization of the diseased parathyroid gland. Localization studies are carried out meticulously in our series and therefore surgical success is increasing.

Özet

Amaç: Primer hiperparatiroidi, artmış parathormon (PTH) salınımına bağlı hiperkalsemi ile seyreden endokrin bozukluktur. Tedavisi, hastalıklı bez ya da bezlerin bilateral/unilateral boyun eksplorasyonu veya odaklanmış paratiroidektomi ile çıkarılmasıdır. Bu çalışmadaki amacımız primer hiperparatiroidi nedeniyle cerrahi uygulanan hastaların sonuçlarını değerlendirmektir. Yöntemler: Kliniğimizde 2013-2017 yılları arasında primer hiperparatiroidi nedeniyle ameliyat edilen hastalar retrospektif olarak incelendi. Hastaların demografik özellikleri, ameliyat öncesi PTH, kalsiyum, fosfor, albümin, D vitamini seviyeleri, paratiroit sintigrafisi ve/veya tek foton emisyonlu bilgisayarlı tomografi, boyun ultrasonografisi bulguları, görüntülemeler arasındaki uyum, ek görüntüleme veya tetkik yapılıp yapılmadığı, uygulanan cerrahi teknik, ameliyat sonrası PTH, kalsiyum seviyeleri, patoloji sonuçları, komplikasyon varlığı, ameliyat sonrası altıncı ay PTH ve kalsiyum seviyeleri, persistans veya rekürrens varlığı kaydedildi. Verilerine ulaşılamayan, sekonder hiperparatiroidi nedeniyle ameliyat edilen hastalar çalışma dışı bırakıldı. Bulgular: Elli dokuz hastanın yaş ortalaması 56±11,2 yıl, kadın/erkek oranı 43/16 idi. Ameliyat öncesi PTH seviyeleri 272±171ng/L, kalsiyum seviyeleri 11,8±0,68 mg/dL idi. Ortanca takip süresi 22 (3-56) aydı. On hasta (%16,9) semptomatik, 49 hasta (%83,1) asemptomatik idi. Hastaların %50,8’ine odaklanmış cerrahi, %1,7’sine bilateral, %18,6’sına unilateral eksplorasyon uygulandı. Ayrıca hastaların %18,6’sına eşlik eden tiroit patolojisi nedeniyle lobektomi, %10,2’sine bilateral total tiroidektomi yapıldı. Bir olguda paratiroit kanseri şüphesi nedeniyle lobektomi uygulandı. Sonuç: Ameliyat öncesi tanının doğru konulması, hastalıklı bezin yerinin tespiti primer hiperparatiroidinin cerrahi başarısını etkileyen en önemli faktörlerdir. Bizim serimizde de lokalizasyon çalışmaları titizlikle yapılmakta ve cerrahi başarı giderek artmaktadır.

🔖

Cite This Article

YÜKSEL, S., FERLENGEZ, E., ÇITLAK, G. (2019). Is Focused Parathyroidectomy Effective in Primary Hyperparathyroidism?. Haseki Tıp Bülteni, Cilt: 57 - Sayı: 4, 345–348. https://ajindex.com/articles/192445

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bilezikian JP, Bandeira L, Khan A, et al. Hyperparathyroidism. Lancet 2018;391:168-78
  2. Wilhelm SM, Wang TS, Ruan DT, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 2016;151:959-68
  3. Van Heerden JA, Weiland LH, ReMine WH, et al. Cancer of the parathyroid glands. Arch Surg 1979;114:475-80
  4. Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009;94:335-9
  5. Fraser WD. Hyperparathyroidism. Lancet 2009;374:145-58
  6. Pasieka JL, Parsons L, Jones J. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 2009;146:1006-13
  7. Sheldon DG, Lee FT, Neil NJ, et al. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 2002;137:1022-6
  8. Udelsman R, Åkerström G, Biagini C, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014;99:3595-606
  9. Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 2011;253:585-91
  10. Van Udelsman B, Udelsman R. Surgery in primary hyperparathyroidism: extensive personal experience. J Clin Densitom 2013;16:54-9
  11. Türkiye Endokrinoloji ve Metabolizma Derneği. Tiroid hastalıkları tanı ve tedavi kılavuzu 2017. Türkiye Klinikleri 2017;157:143-54
  12. Westerdahl J, Lindblom P, Valdemarsson S, et al. Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 2000;135:142-7.